Stock listing

NASDAQ:AXLA Axcella Health Inc Stock

Follow Axcella Health Inc into a list and get an email when it puts out news.

Delisted NASDAQ:AXLA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:AXLA
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Axcella Health Inc on 6ix

Calls
3 calls with a replay · 3 with a transcript · latest Nov 1, 2022
Decks
6 decks · latest Sep 29, 2022

Events

CallWhenStatus
Axcella Health (AXLA) Q3 2022 Earnings CallTue, Nov 01, 2022 · 8:30 AM ETReplay
Axcella Health (AXLA) Q2 2022 Earnings CallFri, Aug 12, 2022 · 8:00 AM ETReplay
Axcella Health (AXLA) Q3 2020 Earnings CallThu, Nov 12, 2020 · 8:30 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
Technical Presentation (September 2022)Technical62 slidesSep 29, 2022
Technical Presentation (August 2022)Technical51 slidesAug 2, 2022
Investor Presentation (January 2022)Investor deck36 slidesJan 10, 2022
Q1 2021 Earnings PresentationEarnings31 slidesMay 6, 2021
Technical Presentation (August 2020)Technical16 slidesAug 5, 2020
Technical Presentation (May 2020)Technical23 slidesMay 6, 2020

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David R. Epstein
Other companies: AgomAb Therapeutics NV (Chairman of the Board · Since at least Mar 18, 2026); Tempus AI, Inc. (Director · Since at least Jun 13, 2024); Pfizer, Inc. (Director · Apr 13, 2026 – Nov 5, 2026 · Past); Seagen Inc (CEO, Director · Nov 9, 2022 – Dec 14, 2023 · Past); OPY Acquisition I Corp (Director · Oct 26, 2021 – Oct 26, 2021 · Past); Senti Biosciences Holdings, Inc. (Director · May 25, 2021 – Jul 13, 2022 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – May 12, 2022 · Past); Evelo Biosciences, Inc. (Director · May 8, 2018 – Jun 30, 2022 · Past); International Flavors & Fragrances, Inc. (Director · Jan 1, 2016 – Nov 2, 2020 · Past)
Director · May 8, 2019 – May 19, 2022 · Past
Paul Sekhri
Other companies: Apnimed, Inc. (Director · Since at least Jul 30, 2026); vTv Therapeutics Inc. (Chairman of the Board, President and Chief Executive Officer · Since at least Aug 1, 2022); Veeva Systems Inc. (Director · Since at least Jun 22, 2016); Longboard Pharmaceuticals Inc (Director · Mar 11, 2021 – Dec 2, 2024 · Past); BiomX Inc. (Director · Oct 2, 2020 – Jul 28, 2021 · Past); Enumeral Biomedical Holdings Inc (Director · Dec 9, 2016 – Dec 9, 2016 · Past); Alpine Immune Sciences Inc (Director · Sep 12, 2016 – Jan 2, 2020 · Past)
Director · May 19, 2022 – May 19, 2022 · Past
Catherine Angell Sohn
Other companies: Maze Therapeutics, Inc. (Director · Since at least Jan 30, 2025); Altimmune, Inc. (Director · Since at least Mar 23, 2023); Rubius Therapeutics Inc (Director · Jul 17, 2018 – May 12, 2022 · Past); Palisade Bio, Inc. (Director · Jan 13, 2014 – Jul 1, 2015 · Past); Lifecore Biomedical, Inc. (Director · Nov 13, 2012 – Jun 4, 2022 · Past); Jazz Pharmaceuticals plc (Director · Jul 27, 2012 – Aug 11, 2023 · Past)
Director · Aug 21, 2019 – May 19, 2022 · Past
David Berry
Other companies: Averin Capital Acquisition Corp. (See Remarks, Director · Since at least Feb 18, 2026); Oaktree Acquisition Corp. III Life Sciences (Director · Since at least Oct 17, 2025); Omega Therapeutics Inc (Director · Jul 29, 2021 – Aug 3, 2021 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – Jun 8, 2016 · Past); Fortune Industries Inc (Director · May 18, 2007 – Mar 19, 2013 · Past)
Director · May 8, 2019 – May 20, 2020 · Past
Robert L Rosiello
Other companies: Seres Therapeutics, Inc. (Director · Since at least Aug 5, 2025); Sana Biotechnology, Inc. (Director · Since at least Jun 5, 2025); Omega Therapeutics Inc (Director · Oct 2, 2024 – Oct 2, 2024 · Past); Evelo Biosciences, Inc. (Director · Apr 14, 2023 – Jun 8, 2023 · Past); Bausch Health Companies Inc. (EVP, Corp Dev & Strategy · Jun 11, 2015 – Dec 5, 2016 · Past)
Director · Oct 10, 2022 – Nov 16, 2022 · Past
Michael Rosenblatt
Other companies: Azenta, Inc. (Director · Sep 4, 2018 – Feb 12, 2024 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – May 12, 2022 · Past); Merck & Company, Inc. (Exec V-P & Chief Med Officer · Dec 16, 2009 – May 10, 2016 · Past)
Director · May 19, 2022 – May 19, 2022 · Past
Thomas Leggett
Other companies: Stoke Therapeutics, Inc. (Chief Financial Officer · Since at least May 7, 2024); Research Alliance Corp II (Director · Mar 17, 2021 – Mar 17, 2021 · Past); Black Diamond Therapeutics, Inc. (Chief Financial Officer · Jan 29, 2020 – Feb 17, 2021 · Past)
SVP Finance, CFO · May 8, 2019 – May 8, 2019 · Past
William D Baird III
Other companies: 2Seventy Bio Inc (President and CEO, Director · Oct 18, 2021 – May 13, 2025 · Past); Bluebird bio Inc (Chief Financial Officer · Feb 11, 2019 – Nov 11, 2021 · Past); Amicus Therapeutics Inc (Chief Financial Officer · Apr 16, 2012 – Oct 15, 2018 · Past)
Director · May 8, 2019 – May 19, 2022 · Past
Christopher A. Viehbacher
Other companies: Braveheart Bio, Inc. (Director · Since at least Aug 5, 2026); Biogen Inc. (President and Chief Executive Officer · Since at least Nov 14, 2022)
Director · May 8, 2019 – May 8, 2019 · Past
Gary P Pisano
Other companies: Patheon N.V. (Director · Jul 20, 2016 – Aug 29, 2017 · Past); Sio Gene Therapies Inc (Director · May 13, 2016 – Apr 28, 2017 · Past)
Director · May 8, 2019 – May 19, 2022 · Past
All 28 people
PersonSeat
Gregory Behar
Other companies: Aimmune Therapeutics Inc (Director · Nov 23, 2016 – Oct 13, 2020 · Past); Seres Therapeutics, Inc. (Director · Jun 25, 2015 – Jun 22, 2023 · Past)
Director · May 8, 2019 – May 20, 2021 · Past
Heidy King-Jones
Other companies: Spyre Therapeutics, Inc. (Chief Legal Officer and Corporate Secretary · Since at least Sep 1, 2023); Provention Bio Inc (Chief Legal Officer · Aug 3, 2020 – Apr 27, 2023 · Past)
General Counsel, SVP Legal · Nov 13, 2019 – Dec 18, 2019 · Past
Laurent Chardonnet
Other companies: Prelude Therapeutics Incorporated (Chief Financial Officer · Nov 29, 2021 – Mar 1, 2024 · Past); Incyte Corporation (VP Finance and Treasurer · Jan 13, 2006 – Jan 13, 2006 · Past)
Chief Financial Officer · Nov 25, 2019 – Feb 9, 2021 · Past
Margaret Koziel
Other companies: Innoviva, Inc. (Chief Medical Officer · Jul 31, 2023 – Jul 31, 2023 · Past)
Chief Medical Officer · Dec 1, 2021 – Mar 1, 2023 · Past
Martin Hendrix
Other companies: Prometheus Biosciences Inc (Director · Mar 11, 2021 – Jun 16, 2023 · Past)
Director · May 19, 2022 – May 19, 2022 · Past
Shane Maltbie
Other companies: Hillevax Inc (Chief Financial Officer · Since at least Jan 6, 2023)
See Remarks · Aug 21, 2019 – Aug 21, 2019 · Past
Shreeram Aradhye
Other companies: Dicerna Pharmaceuticals Inc (EVP & Chief Medical Officer · Sep 8, 2020 – Dec 28, 2021 · Past)
Director · May 22, 2019 – May 20, 2021 · Past
Stephen Hoge
Other companies: Moderna, Inc. (President · Since at least Dec 7, 2018)
Director · May 8, 2019 – May 20, 2021 · Past
Stephen Mitchener
Other companies: Karyopharm Therapeutics Inc. (SVP, Chief Business Officer · Dec 31, 2020 – Feb 28, 2023 · Past)
SVP & Chief Business Officer · May 8, 2019 – Dec 18, 2019 · Past
Torben Straight Nissen
Other companies: Rubius Therapeutics Inc (President · Jul 17, 2018 – Jul 24, 2019 · Past)
Director · Oct 10, 2022 – Nov 16, 2022 · Past
Alison D SchecterPresident - Research & Dev. · Mar 15, 2021 – Feb 8, 2022 · Past
CRISTINA RondinoneDirector · May 8, 2019 – May 19, 2022 · Past
Manu ChakravarthySVP & Chief Medical Officer · May 8, 2019 – Feb 9, 2021 · Past
Paul FehlnerSVP & Chief Legal Officer · May 8, 2019 – Feb 17, 2023 · Past
Robert CraneChief Financial Officer · Feb 8, 2022 – Mar 16, 2022 · Past
Tony TramontinSVP & Chief Scientific Officer · May 8, 2019 – Dec 18, 2019 · Past
Virginia R DeanSVP, Chief People Officer · Jun 21, 2021 – Feb 8, 2022 · Past
William HinshawPresident & CEO, Director · Sep 29, 2020 – Feb 17, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Axcella Health Inc.